Results 91 to 100 of about 2,550,374 (236)

In Vivo Partial Cell Reprogramming With Yamanaka Factors Reduced Ischemic Brain Damage in Aging Mice

open access: yesAging Cell, Volume 25, Issue 11, November 2026.
Short‐term cyclic partial reprogramming with Yamanaka factors protects aged mice from ischemic brain injury, preserving cognitive function, myelin integrity, and neuronal density, supporting partial reprogramming as a promising neuroprotective intervention in aging.
Paula R. Mallavibarrena   +5 more
wiley   +1 more source

Thrombolytic Therapy [PDF]

open access: yesClinical and Applied Thrombosis/Hemostasis, 2013
A. Nicolaides   +31 more
openaire   +2 more sources

Modern methods for the estimation of thrombolysis efficiency in patients with myocardial infraredness with the rise of ST

open access: yesЛечащий Врач, 2021
This article presents a literature review dedicated to modern methods of noninvasive evaluation of efficacy of thrombolytic therapy in patients with ST-segment elevation in myocardial infarction. D-dimer as a probable marker of myocardial reperfusion and
E. M. Podgornaya   +3 more
doaj  

Influence of thrombolytic therapy on the patterns of ventricular septal rupture after acute myocardial infarction.

open access: yes, 2002
BACKGROUND: Post-myocardial infarction ventricular septal defect (VSD) complicates approximately 2% of myocardial infarctions. Thrombolytic therapy may accelerate the time from myocardial infarction to VSD formation.
Schofield, PM   +5 more
core   +1 more source

Initiation of SGLT2 Inhibitors Versus DPP‐4 Inhibitors in Metformin Users and Risk of Incident Depression: A Nationwide, Claims‐Based Active‐Comparator New‐User Study

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 10765-10779, November 2026.
ABSTRACT Aims To examine the association between initiation of sodium‐glucose cotransporter‐2 (SGLT2) inhibitors and risk of incident depression compared with dipeptidyl peptidase‐4 (DPP‐4) inhibitors among adults with newly diagnosed Type 2 diabetes receiving metformin.
Sangwoo Park   +5 more
wiley   +1 more source

The recanalization rate of femoral artery after thrombolytic therapy at various time points (%) (n = 72).

open access: yes, 2016
The recanalization rate of femoral artery after thrombolytic therapy at various time points (%) (n = 72).
Lina Guan (396341)   +2 more
core   +1 more source

Tailored thrombolytic therapy. A perspective

open access: yes, 1993
BACKGROUND. In contrast with current standard regimens, it seems more appropriate to tailor thrombolytic therapy to individual patient characteristics. A proposed model for such tailored therapy is based on individual assessment of benefits and risks of ...
Simoons, M.L. (Maarten)   +1 more
core   +1 more source

Management of Acute Superior Mesenteric Artery Occlusion by Thrombolytic Therapy

open access: yesCase Reports in Gastroenterology, 2009
Acute occlusion of the superior mesenteric artery (SMA) causes extensive bowel necrosis, resulting in a poor prognosis with an extremely high mortality rate. An 82-year-old woman was admitted to our hospital with the complaint of abdominal pain.
Shinichi Okamura   +13 more
doaj   +1 more source

Bioinspired Adaptive Surfaces for Intelligent Liquid Manipulation: Progressing From Passive and Active to Hybrid Strategies

open access: yesAdvanced Materials, Volume 38, Issue 56, 8 October 2026.
This review examines passive, active, and hybrid liquid manipulation strategies, highlighting hybrid approaches as an emerging route to reconcile energy efficiency with adaptive control. By actively reconstructing passive surfaces to store programmable interfacial energy, hybrid systems enable flexible yet low‐power liquid transport, with perspectives ...
Jiaqi Miao   +3 more
wiley   +1 more source

Is Thrombolytic Therapy Safe When Used to Treat Elderly Patients? [PDF]

open access: yes, 2011
Recently, research has been conducted to determine if thrombolytic therapy works to dissolve clots and if it is a safe treatment option. The specific purpose of this study is to determine if thrombolytic therapy is safe for use in the elderly. This study
Yaeger, Daniel
core  

Home - About - Disclaimer - Privacy